PositiveID Corporation (PSID)

William J. Caragol, Chairman and CEO of PositiveID (OTCQB: PSID) , called in to SmallCapVoice.com, Inc. to discuss the recently announced definitive agreements with an institutional investor (“Investor”) for an aggregate subscription amount of $4,000,000. The Company will use the proceeds to continue the development of its Firefly Dx, a real-time, hand held, polymerase chain reaction (PCR) pathogen detection system, restructure the Company’s existing debt, and for general working capital.

PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.